Back to regulatory watch
Federal RegisterGuidance and regulationPublished Aug 12, 2026
Government Owned Invention Available for License: Monoclonal Antibody (RO4) That Reacts With the Juxta-Membrane Region of Mesothelin
Updated 4 hours ago ()
The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for a novel monoclonal antibody (mAb), RO4, that can be used to treat mesothelin (MSLN) expressing cancers.
- Tags
- information blocking, Notice, Health and Human Services Department, National Institutes of Health
- Related exam domains
- None matched
- Source record id
- 2026-16443
- First seen by InfoSec Signals
- Sep 23, 2026
Source: Federal Register API, Office of the Federal Register, National Archives and Records Administration about this source more from it
Exam domain labels come from a keyword heuristic and are study hints, not an official mapping. The summary is the publisher's own text, shortened; the linked record is authoritative.